Related by context. All words. (Click for frequent words.) 78 gemcitabine 76 docetaxel 75 doxorubicin 74 paclitaxel 74 etoposide 73 Cisplatin 72 5FU 72 cetuximab 72 trastuzumab 72 topotecan 72 carboplatin 71 bortezomib 71 cyclophosphamide 71 5 fluorouracil 70 temozolomide 70 chemotherapy regimens 70 docetaxel chemotherapy 70 imatinib 70 erlotinib 70 chemotherapeutic agents 70 bevacizumab 70 chemoradiation 69 rituximab 69 5 FU 69 fluorouracil 69 pemetrexed 68 oxaliplatin 68 idarubicin 68 irinotecan 68 neoadjuvant chemotherapy 68 chemotherapy 68 capecitabine 68 pegylated liposomal doxorubicin 68 carboplatin paclitaxel 67 TACE 67 taxanes 67 mitoxantrone 67 Taxotere 67 gefitinib 67 FOLFOX 67 chemoradiotherapy 67 gemcitabine chemotherapy 67 cisplatin chemotherapy 67 nab paclitaxel 66 Gemcitabine 66 vinorelbine 66 sorafenib 66 interferon 66 paclitaxel carboplatin 66 chemotherapy regimen 66 FOLFIRI 66 anthracyclines 66 daunorubicin 66 cytarabine 66 sunitinib 66 Irinotecan 66 chemotherapies 66 tamoxifen 66 mycophenolate mofetil 66 dacarbazine 66 decitabine 66 sorafenib Nexavar 66 dose dexamethasone 65 epirubicin 65 adriamycin 65 paclitaxel chemotherapy 65 azathioprine 65 chemotherapeutic agent 65 neoadjuvant 65 interferon alfa 65 leucovorin 65 azacitidine 65 chemotherapy docetaxel 65 fulvestrant 65 irinotecan chemotherapy 64 adjuvant therapy 64 imetelstat 64 zoledronic acid 64 methotrexate 64 dexamethasone 64 Doxil ® 64 FOLFOX4 64 cytotoxic chemotherapy 64 standard chemotherapy regimen 64 relapsed ovarian cancer 64 chemotherapeutic drugs 64 bleomycin 64 cytotoxic 64 Fludara 64 trabectedin 64 HER2 positive metastatic breast 64 paclitaxel Taxol 64 taxane 63 interferon alfa 2a 63 melphalan 63 temozolomide TMZ 63 vincristine 63 chlorambucil 63 alkylating agents 63 advanced NSCLC 63 Taxol 63 dose cytarabine 63 lapatinib 63 adjuvant chemotherapy 63 resistant ovarian cancer 63 gemcitabine Gemzar 63 hormonal therapy 63 pertuzumab 63 chemotherapeutic drug 63 5-FU/LV 63 doxorubicin cyclophosphamide 63 exemestane 63 docetaxel Taxotere 63 bevacizumab Avastin ® 63 dexamethasone Decadron 63 Taxotere ® 63 alkylating agent 63 fludarabine 63 NRTIs 63 metastatic renal cell carcinoma 63 CHOP chemotherapy 63 Platinol ® cisplatin 63 vandetanib 62 gemcitabine carboplatin 62 gemcitabine cisplatin 62 Cyclophosphamide 62 chemotherapeutic regimens 62 postoperative chemotherapy 62 lamivudine 62 BEACOPP 62 oral clodronate 62 peginterferon 62 EGFR 62 dasatinib 62 monotherapy 62 docetaxel Taxotere ® 62 lenalidomide 62 imatinib Gleevec 62 chemotherapeutics 62 chemotherapy cisplatin 62 Docetaxel 62 erlotinib Tarceva ® 62 neoadjuvant therapy 62 Trastuzumab 62 bevacizumab Avastin 62 pegylated interferon 62 raltegravir 62 PegIFN RBV 62 Peg IFN 62 estramustine 62 Bortezomib 62 ritonavir boosted 62 standard chemotherapy regimens 62 sorafenib Nexavar ® 62 5 FU leucovorin 62 EBRT 62 oblimersen 62 liposomal doxorubicin 62 pyrazinamide 62 Folfox 62 Platinol 61 G CSF 61 temsirolimus 61 tyrosine kinase inhibitor 61 taxane chemotherapy 61 anastrozole 61 adjuvant radiation 61 eribulin 61 taxane therapy 61 bendamustine 61 plus dexamethasone 61 glucocorticoids 61 xenograft models 61 plus gemcitabine 61 Adriamycin 61 milatuzumab 61 DFMO 61 fluoropyrimidine 61 Gefitinib 61 Taxotere docetaxel 61 cyclophosphamide methotrexate 61 chemo radiotherapy 61 Carboplatin 61 azacytidine 61 Capecitabine 61 Cremophor 61 chemotherapeutic 61 calcitriol 61 goserelin 61 pegylated interferon alfa 2a 61 ixabepilone 61 DMARDs 61 pancreatic adenocarcinoma 61 metastatic RCC 61 cisplatin gemcitabine 61 interferon alfa 2b 61 gefitinib Iressa 61 mapatumumab 61 clodronate 61 arsenic trioxide 61 ABVD 61 Cytoxan 61 NSCLC 61 Pemetrexed 60 Herceptin trastuzumab 60 DMARD 60 seliciclib 60 Imprime PGG 60 #mg/m# [002] 60 fibrinolytic 60 anthracycline 60 paclitaxel cisplatin 60 IFN alpha 60 FOLFOX6 60 metastatic colorectal cancer 60 DAPT 60 ribavirin 60 cidofovir 60 trans retinoic acid ATRA 60 GnRH agonists 60 Fludarabine 60 platinum refractory 60 intravenous bisphosphonates 60 taxol 60 octreotide LAR 60 tyrosine kinase inhibitors 60 mitomycin 60 trastuzumab Herceptin ® 60 DOXIL 60 tamoxifen therapy 60 bicalutamide 60 Hycamtin 60 irinotecan doxorubicin oxaliplatin paclitaxel 60 fallopian tube cancers 60 MGd 60 vinca alkaloids 60 pCR 60 pegfilgrastim 60 concurrent chemoradiation 60 interferon alpha 60 androgen deprivation 60 Erlotinib 60 metastatic 60 vorinostat 60 cilengitide 60 idraparinux 60 telaprevir dosed 60 VIDAZA 60 erlotinib Tarceva 60 angiogenesis inhibitor 60 Pegylated Interferon 60 Halaven 60 talabostat 60 Chemotherapy 60 metastatic breast cancer 60 5 Fluorouracil 60 Etoposide 60 radiochemotherapy 59 gemcitabine Gemzar ® 59 adefovir 59 bone metastasis 59 estrogen receptor 59 mRCC 59 EGF receptor 59 antiandrogen 59 proteasome inhibitors 59 trans retinoic acid 59 GM CSF 59 rituximab Rituxan 59 XELOX 59 peginterferon alfa 2a 59 Bevacizumab 59 IMC A# 59 recurrent NSCLC 59 pegylated interferon alfa 2b 59 cisplatin carboplatin 59 Doxil 59 chemotherapy gemcitabine 59 melphalan prednisone 59 antitumor activity 59 peg IFN 59 locoregional 59 preoperative chemotherapy 59 liver metastases 59 trastuzumab Herceptin R 59 CA4P 59 Vectibix 59 TNF inhibitor 59 ribavirin RBV 59 mitoxantrone chemotherapy 59 APTIVUS r 59 paricalcitol 59 protease inhibitor 59 biochemical relapse 59 letrozole 59 metformin 59 SCCHN 59 HER2 negative 59 ERCC1 59 superficial bladder cancer 59 vinca alkaloid 59 adjuvant tamoxifen 59 cytotoxicity 59 celecoxib 59 low dose dexamethasone 59 adjuvant 59 cabazitaxel 59 refractory ovarian cancer 59 EGFR tyrosine kinase inhibitors 59 Pegasys ® 59 tumor progression 59 docetaxel Taxotere R 59 grade gliomas 59 antitumor effects 59 chemotherapy FOLFOX 59 glucocorticoid 59 imatinib therapy 59 EGFR TKI 59 paclitaxel Taxol R 59 CsA 59 anti leukemic 59 tumors 59 anthracycline taxane 59 alfa 2a 59 PLX# 59 Faslodex 58 Amrubicin 58 administered orally 58 external beam radiotherapy 58 YONDELIS 58 cetuximab Erbitux ® 58 operable breast cancer 58 luteinizing hormone releasing 58 neurologic progression 58 trastuzumab Herceptin 58 biologic therapy 58 WT1 58 sulfasalazine 58 colon carcinoma 58 Mitomycin C 58 Platinol ® 58 T DM1 58 Methotrexate 58 mTOR inhibitors 58 relapsed CLL 58 NRTI 58 interferon IFN 58 chemoradiation therapy 58 microtubule inhibitor 58 CLL cells 58 interferon ribavirin 58 heavily pretreated patients 58 low dose cytarabine 58 PARP inhibitor 58 chemoresistance 58 HER2 positive breast cancer 58 lenalidomide dexamethasone 58 weekly subcutaneous injections 58 Lenalidomide 58 Doxorubicin 58 pegylated interferon alfa 58 immunosuppressant 58 Tamoxifen 58 intravesical 58 distant metastasis 58 mg m² 58 N acetylcysteine 58 6 mercaptopurine 58 brain metastases 58 infusional 5-FU/LV 58 Taxotere chemotherapy 58 overlapping toxicities 58 metastatic colorectal carcinoma 58 GISTs 58 anakinra 58 Xeloda 58 cisplatin resistant 58 Taxol paclitaxel 58 SCH # 58 amphotericin B 58 lapatinib Tykerb 58 fluorouracil leucovorin 58 Sorafenib 58 endocrine therapy 58 aromatase inhibitor 58 itraconazole 58 pomalidomide 58 fluconazole 58 distant metastases 58 depsipeptide 58 pegylated interferon alpha 58 cytarabine daunorubicin 58 tumor recurrence 58 epirubicin cyclophosphamide 58 IFN α 58 surgical debulking 58 atazanavir 58 Erbitux cetuximab 58 5 fluorouracil leucovorin 58 #mg/m# [001] 58 capecitabine Xeloda 58 FOLFOX chemotherapy 58 Adjuvant chemotherapy 58 factor G CSF 58 Peginterferon 58 anti TNF 58 PREZISTA r 58 fallopian tube carcinoma 58 octreotide 58 cyclophosphamide chemotherapy 58 clopidogrel 58 Cetuximab 58 cranial radiation 58 nelfinavir 58 intratumoral injection 58 TNFa 58 thalidomide Thalomid 58 anticancer agents 58 immunomodulator 58 TAXOTERE R 58 lopinavir r 57 Taxotere R 57 3TC lamivudine Epivir 57 mutated KRAS 57 heavily pretreated 57 flavopiridol 57 metastatic disease 57 myeloablative 57 EGFR inhibitors 57 olaparib 57 metastatic colon cancer 57 ELOXATIN 57 administered subcutaneously 57 abacavir lamivudine 57 bevacizumab Avastin R 57 Akt activation 57 dasatinib Sprycel 57 Gemzar ® 57 topoisomerase 57 indomethacin 57 panobinostat 57 nilotinib 57 Gleevec resistant 57 solid tumors 57 adecatumumab 57 adalimumab 57 chronic lymphocytic leukemia CLL 57 free survival PFS 57 letrozole Femara 57 PSMA ADC 57 VEGF inhibitors 57 bortezomib Velcade 57 K ras mutations 57 immunosuppressive agents 57 cetuximab Erbitux R 57 hydroxychloroquine 57 Pharmacokinetics PK 57 tumor cells 57 mitomycin C 57 VELCADE melphalan 57 fondaparinux 57 endoxifen 57 Lapatinib 57 flutamide 57 plus prednisone 57 mCRC patients 57 Neoadjuvant 57 radiation chemoradiation 57 dasatinib Sprycel ® 57 allopurinol 57 metastases 57 anthracycline chemotherapy 57 paclitaxel Taxol ® 57 GRN#L 57 Paraplatin ® carboplatin 57 xenograft tumors 57 Fulvestrant 57 pegylated 57 metastatic malignant 57 amrubicin 57 KRAS mutant tumors 57 LHRH agonist 57 steroid dexamethasone 57 HGS ETR1 57 iniparib 57 HER2 positive tumors 57 adalimumab Humira 57 metastatic colorectal 57 chemotherapeutic regimen 57 Temozolomide 57 KRAS status 57 cytotoxic agents 57 interferon beta 57 tiotropium bromide 57 corticosteroids 57 ALIMTA 57 KRAS mutations 57 severe neutropenia 57 hematologic toxicity 57 Paraplatin ® 57 IFN beta 57 sorafenib tablets 57 mg kg dose 57 doxorubicin docetaxel 57 FOLFIRINOX 57 Azacitidine 57 nilotinib Tasigna ® 57 Xelox 57 entecavir 57 plus ribavirin 57 nucleoside reverse transcriptase inhibitor 57 antithymocyte globulin 57 bone metastases 57 anticancer therapy 57 Camptosar ® 57 ISTODAX 57 lenalidomide Revlimid R 57 ceftriaxone 57 ERBITUX 57 abiraterone 57 forskolin 57 Velcade bortezomib 57 Fluorouracil 57 Oxaliplatin 57 VAPRISOL 57 dacarbazine DTIC 57 Mitoxantrone 57 palifermin 57 CIMZIA TM 57 surrogate endpoint 57 allogeneic SCT 57 camptothecin 57 relapsed refractory 57 platelet inhibitor 57 Exemestane 57 erythropoietic 57 dose clopidogrel 57 viral kinetics 57 ethambutol 57 Zoledronic acid 57 recurrent glioblastoma multiforme 57 vincristine doxorubicin 57 biologic DMARD 57 recurrent ovarian cancer 57 Trabectedin 57 receptor tyrosine kinase inhibitor 57 isoproterenol 57 sirolimus 57 Cloretazine 57 tipranavir 57 peg interferon 57 PREZISTA rtv 57 HER2 positive 57 Taxol ® 56 TNF inhibitors 56 zalutumumab 56 Copegus ribavirin 56 EGFR mutation 56 CANCIDAS 56 efavirenz EFV 56 Alkeran 56 Torisel 56 histone deacetylase inhibitor 56 Tarceva 56 pioglitazone 56 Mylotarg 56 LY# [003] 56 doxorubicin Adriamycin 56 prostate carcinoma 56 IGF 1R 56 gamma secretase inhibitor 56 FOLFIRI alone 56 etanercept 56 papillary renal cell carcinoma 56 panitumumab 56 cardiac toxicity 56 PKC# 56 PGE2 56 doxorubicin HCl liposome injection 56 zoledronate 56 placebo dexamethasone 56 antitumor effect 56 cetuximab Erbitux 56 FOLPI 56 rapamycin 56 lung metastases 56 LMWH 56 cyclophosphamide Cytoxan 56 hormone receptor positive 56 nucleoside analog 56 Ontak 56 EGFR expressing 56 antiangiogenic therapy 56 Ceplene/IL-2 56 anastrazole 56 xanthine oxidase inhibitor 56 relapsing multiple sclerosis 56 GnRH agonist 56 granisetron 56 aprepitant 56 anti androgen 56 NNRTIs 56 remission induction 56 abiraterone acetate 56 adjuvant radiotherapy 56 conventional chemotherapies 56 mg/m2 dose 56 mcg kg 56 peritoneal carcinomatosis 56 ganciclovir 56 Fludara ® 56 infliximab 56 Anthracycline 56 resectable 56 cytotoxic therapy 56 unresectable 56 neoadjuvant treatment 56 INTELENCE 56 paclitaxel poliglumex 56 tamsulosin 56 levodopa 56 protease inhibitor PI 56 radiotherapy RT 56 antiangiogenic 56 adjuvant cisplatin 56 TRAIL induced apoptosis 56 endocrine therapies 56 poly ADP ribose polymerase 56 toxicities 56 cell lung cancer 56 eribulin mesylate 56 dacarbazine chemotherapy 56 xenografts 56 HER2 56 relapsed MM 56 Dasatinib 56 Bcl xL 56 raloxifene Evista 56 Celecoxib 56 EpCAM 56 Vidaza ® 56 alpha interferons 56 median PFS 56 injected subcutaneously 56 L dopa 56 methotrexate therapy 56 evaluating tivozanib 56 sunitinib malate 56 cyclosporin 56 alefacept 56 hepatic metastases 56 induced apoptosis 56 Seliciclib 56 alpha interferon 56 intravenous infusions 56 Ixempra 56 transgene expression 56 nitazoxanide 56 mCRC 56 leukemia AML 56 bladder cancers 56 3TC 56 pyridostigmine 56 FluCAM 56 Paclitaxel 56 Ribavirin 56 cell lymphoma CTCL 56 irbesartan 56 ritonavir 56 axitinib 56 febrile neutropenia 56 anticancer agent 56 plus 5-FU/LV 56 virologic failure 56 phenoxodiol 56 intramuscularly 56 LEXIVA r 56 basal cell carcinoma BCC 56 cystectomy 56 radiofrequency ablation RFA 56 DMARDS 56 IGFBP 3 56 vancomycin 56 EGFR TKIs 56 chemoembolization 56 refractory NSCLC 56 clomiphene 56 tumor regression 56 EGFr 56 colorectal liver metastases 56 tenofovir Viread 56 TKIs 56 glioma cells 56 Tykerb 56 LHRH agonists 56 uric acid lowering 56 chemoresistant 56 Revlimid lenalidomide 56 zidovudine 56 induces apoptosis 56 TNF antagonist 56 APTIVUS 56 CIMZIA ™ 56 tiotropium 56 amprenavir 56 melanoma tumors 56 Vincristine 56 liposomal formulation 56 capecitabine Xeloda R 56 PSADT 56 PARP inhibitors 56 leflunomide 56 Rituximab 56 advanced hepatocellular carcinoma 56 molecularly targeted 56 anti EGFR antibody 56 microwave hyperthermia 56 tyrosine kinase inhibitors TKIs 56 dexrazoxane 56 proteasome inhibitor bortezomib 56 insulin glargine 56 Navelbine 56 Topotecan 55 cediranib 55 Epirubicin 55 multikinase inhibitor 55 cytostatic 55 intravenous cyclophosphamide 55 bortezomib Velcade R 55 ALIMTA cisplatin 55 Neulasta ® 55 radiotherapy 55 antitumor 55 tenofovir emtricitabine 55 metastatic NSCLC 55 conventional DMARDs 55 cyclophosphamide doxorubicin vincristine 55 4mg/kg 55 receiving VICTRELIS 55 low dose ritonavir 55 interferons 55 rhTSH 55 stage IIIb IV 55 stage IIIB 55 virologic response 55 ALA PDT 55 LHRH 55 DLBCL 55 pentamidine 55 HDAC inhibitors 55 vinblastine 55 Flu Cy 55 administered intravenously 55 ERBB2 55 PXD# 55 sulfonylurea 55 HER2 receptor 55 saline placebo 55 metastatic lung cancer 55 Imatinib 55 dose regimens 55 panitumumab Vectibix 55 dosage regimens 55 tegafur 55 receiving highly emetogenic 55 BMS # 55 recurrent GBM 55 axillary lymph node dissection 55 tinidazole 55 TTF Therapy 55 STAT3 55 lopinavir 55 active metabolite 55 leukemia CLL 55 rifampicin 55 androgen blockade 55 peginterferon alfa 2b 55 HGS# 55 DMARD therapy 55 tumor shrinkage 55 CTLA 4 55 Tarceva TM 55 micrometastases 55 dose melphalan 55 denileukin diftitox 55 follicular NHL 55 docetaxel prednisone 55 Toxicities 55 clopidogrel Plavix 55 androgen suppression 55 Everolimus 55 hepatocellular carcinoma HCC 55 Telcyta 55 lung tumors 55 autologous transplants 55 PI3K inhibitor 55 mTOR mammalian target 55 Telintra 55 PC3 cells 55 imatinib Gleevec ® 55 NMIBC 55 FUSILEV enhances 55 Alemtuzumab 55 captopril 55 T#I [002] 55 IMGN# 55 anticancer drugs 55 degarelix 55 interferon beta 1a 55 BRAF mutation 55 isoniazid 55 pazopanib 55 Gemzar gemcitabine 55 breast carcinoma 55 androgen deprivation therapy 55 darunavir ritonavir 55 ibandronate 55 lymphomas 55 microtubule targeting 55 AKT inhibitor 55 nucleoside analogues 55 epirubicin cisplatin 55 intravenous dosing 55 disease progression 55 complete cytogenetic response 55 sorafenib Nexavar R 55 medroxyprogesterone acetate 55 recombinant erythropoietin 55 piperacillin tazobactam 55 enzastaurin 55 Bleomycin 55 fosamprenavir 55 gastrointestinal stromal tumors 55 teriflunomide 55 ototoxicity 55 immunosuppressive 55 intravesical instillation 55 HDACi 55 Chemophase 55 cis retinoic acid 55 Proxinium TM 55 Vandetanib 55 epithelial tumors 55 tocilizumab 55 relapsed SCLC 55 OPAXIO 55 TYKERB 55 nonsmall cell lung cancer 55 refractory AML 55 DOXIL ® 55 #mg/kg [002] 55 EGFR expressing mCRC 55 EGFR inhibitor 55 metastatic relapsed 55 ifosfamide 55 corticosteroid dexamethasone 55 locoregional recurrence 55 8mg/kg 55 taxotere 55 Camptothecin 55 prednisone prednisolone 55 cytoreductive surgery 55 prostate cancer AIPC 55 recurrent metastatic 55 metastatic malignant melanoma 55 cytoreduction 55 Camptosar ® irinotecan 55 grade glioma 55 MDM2 55 NF kappaB activation 55 rFSH 55 nonmyeloablative 55 temozolomide Temodar 55 meropenem 55 darunavir 55 Combination therapy 55 complete cytogenetic 55 glioblastoma multiforme GBM 55 busulfan 55 inhibitory effects 55 MetMAb 55 cyclin D1 55 survivin 55 unresectable stage 55 hormonal therapies 55 apoptotic pathway 55 Interferon alfa 55 nucleoside analogue 55 PD LID 55 Pegasys peginterferon alfa 2a 55 metastatic tumors 55 olmesartan 55 Tarceva erlotinib 55 unfractionated heparin 55 CYC# 55 Preclinical studies 55 rhGH 55 palliative radiotherapy 55 HER2 + 55 teriparatide 55 pamidronate 55 neuroblastoma cells 55 cyclin E 55 tacrolimus ointment 55 retinoid 55 NNRTI 55 anti mitotic 55 glargine 55 transfected 55 AEG# 55 Interferon 54 PegIFN 54 Pegasys plus Copegus 54 WBRT 54 Zolinza 54 recurrent glioblastoma 54 oral allopurinol 54 colorectal cancer liver metastases 54 Degarelix 54 beclomethasone dipropionate 54 dose cyclophosphamide 54 Rituxan rituximab 54 metastatic prostate cancer 54 advanced unresectable 54 fluvastatin 54 BCG refractory 54 nonmetastatic 54 Xanafide 54 Herceptin 54 glatiramer acetate 54 intraperitoneal injection 54 invasive bladder 54 radiation therapy 54 bezafibrate 54 Cytarabine 54 squamous histology 54 farletuzumab 54 endostatin 54 follicular lymphoma FL 54 mycophenolate mofetil MMF 54 mg/m2 54 Tumor Necrosis Factor 54 antimetabolite 54 comparator arm 54 IV bisphosphonates 54 Xcytrin 54 KIT mutations 54 interferon therapy 54 TORISEL 54 peginterferon alpha 2a 54 mutated KRAS gene 54 PC# cells 54 neurotoxicity 54 partial remissions 54 visilizumab 54 carcinoma 54 anti angiogenic agent 54 ASCT 54 mTOR inhibitor 54 nucleoside reverse transcriptase inhibitors 54 TNF α 54 GEMZAR 54 anti proliferative 54 abciximab 54 methotrexate MTX 54 active comparator 54 chemo 54 VICTRELIS 54 splenectomized patients 54 EUS FNA 54 intradermal injection 54 hydralazine 54 potentially hepatotoxic 54 inhibitor RG# 54 FK# 54 voriconazole 54 dose interleukin 54 dalteparin 54 imipenem 54 antiretroviral regimens 54 ISF# 54 subcutaneous SC 54 overexpression 54 antihypertensive therapy 54 Vidofludimus 54 darunavir r 54 Aptivus ® 54 sustained virological response 54 urothelial cancer 54 Decitabine 54 LHRH receptor positive 54 colorectal carcinoma 54 mesothelin 54 intravenously administered 54 TNFα 54 Voreloxin 54 EFAPROXYN 54 iNOS 54 sevelamer